Association CYP3A5 gene polymorphisms with tacrolimus blood concentration in heart transplant recipients

被引：0
|
作者：
Gichkun, Olga [1 ]
Shevchenko, Olga [1 ]
Koloskova, Nadegda [1 ]
Shmerko, Natalia [1 ]
Ilchuk, Maria [1 ]
Shevchenko, Alex [1 ]
机构：
[1] Shumakov Natl Med Res Ctr Transplantol & Artifici, Moscow, Russia
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.040
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [41] Effect of CYP3A5 Gene Polymorphisms on Tacrolimus Blood Concentrations and Adverse Events in Allogeneic Hematopoietic Stem Cell Transplant Patients
    Jiang, Jia
    Luan, Jiajie
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (07) : 1678 - 1682
  • [42] Meta-analysis of the effects of CYP3A5*3 gene polymorphisms on tacrolimus blood concentration and effectiveness in Chinese patients with membranous nephropathy
    Dai, Xiaona
    Yuan, Fang
    Chai, Lan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] Influence of CYP3A4*1B and CYP3A5*1 polymorphisms on tacrolimus exposure in Tunisian kidney transplant recipients
    Ben Fredj, N.
    Kerkni, E.
    Baptiste, W. Jean
    Chaabane, A.
    Hammouda, M.
    Kolsi, A.
    Skhiri, H.
    Boughattas, N.
    Aouam, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 62 - 62
  • [44] Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
    Zuo, Xiao-cong
    Ng, Chee M.
    Barrett, Jeffrey S.
    Luo, Ai-jing
    Zhang, Bi-kui
    Deng, Chen-hui
    Xi, Lan-yan
    Cheng, Ke
    Ming, Ying-zi
    Yang, Guo-ping
    Pei, Qi
    Zhu, Li-jun
    Yuan, Hong
    Liao, Hai-qiang
    Ding, Jun-jie
    Wu, Di
    Zhou, Ya-nan
    Jing, Ning-ning
    Huang, Zhi-jun
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (05): : 251 - 261
  • [45] CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients
    Htun, Y. Y.
    Swe, H. K.
    Saw, T. M.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (04) : 1034 - 1040
  • [46] Association between the CYP3A5*1 Allele, Tacrolimus Concentrations and Renal Function in Lung Transplant Recipients.
    Schoeppler, K.
    Kiser, T.
    Aquilante, C.
    Fish, D.
    Zamora, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 302 - 302
  • [47] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [48] The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients
    Zhaolin Chen
    Xi Cheng
    Liwen Zhang
    Liqin Tang
    Yan Fang
    Hongxiao Chen
    Lei Zhang
    Aizong Shen
    Pharmacological Reports, 2021, 73 : 1418 - 1426
  • [49] The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients
    Chen, Zhaolin
    Cheng, Xi
    Zhang, Liwen
    Tang, Liqin
    Fang, Yan
    Chen, Hongxiao
    Zhang, Lei
    Shen, Aizong
    PHARMACOLOGICAL REPORTS, 2021, 73 (05) : 1418 - 1426
  • [50] Influence of the Cyp3a5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients
    Ferraresso, Mariano
    Tirelli, Amedea
    Ghio, Luciana
    Grillo, Paolo
    Martina, Valentina
    Torresani, Erminio
    Edefonti, Alberto
    PEDIATRIC TRANSPLANTATION, 2007, 11 (03) : 296 - 300
12345